Cerebrospinal fluid and plasma leptin measurements: Covariability with dopamine and cortisol in fasting humans

被引:49
作者
Hagan, MM
Havel, PJ
Seeley, RJ
Woods, SC
Ekhator, NN
Baker, DG
Hill, KK
Wortman, MD
Miller, AH
Gingerich, RL
Geracioti, TD
机构
[1] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45267 USA
[2] Vet Affairs Med Ctr, Psychiat Serv, Cincinnati, OH 45220 USA
[3] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA
[4] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA
[5] Linco Res Inc, St Charles, MO 63304 USA
关键词
D O I
10.1210/jc.84.10.3579
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leptin (OB protein) is an important signal in the regulation of energy balance. Leptin levels correlate with adiposity, but also decrease acutely with caloric restriction and increase with refeeding. The brain is an established critical site of leptin function, yet little is known about leptin concentrations in the central nervous system relative to plasma levels, psychiatric diagnoses, and other endocrine parameters. Therefore, using a novel ultrasensitive leptin assay, we explored relationships of human plasma and cerebrospinal fluid (CSF) leptin levels to body mass index, smoking, posttraumatic stress disorder diagnosis, and levels of dopamine, monoamine metabolites, beta-lipotropin, glucocorticoid, and thyroid and cytokine hormones. A strong linear relation between CSF and plasma leptin levels in the am (r = 0.63; P < 0.002) and afternoon (r = 0.90; P < 0.0001) was revealed. CSF and plasma leptin concentrations decreased during a 12- to 20-h period of fasting. A strong association was found between plasma leptin and CSF dopamine levels (r = 0.74; P < 0.01) as well as between CSF leptin levels and urinary free cortisol (r = 0.73; P < 0.01). Both of these parameters covaried with leptin independently of adiposity, as estimated by body mass index. Implications for leptin transport, regulation, and its potential role in therapeutic strategies for obesity and diabetes are discussed.
引用
收藏
页码:3579 / 3585
页数:7
相关论文
共 59 条
[31]  
Koistinen HA, 1998, EUR J CLIN INVEST, V28, P894
[32]  
KOSMAN ME, 1968, CLIN PHARMACOL THER, V9, P240
[33]   Bromocriptine/SKF38393 ameliorates islet dysfunction in the diabetic (db/db) mouse [J].
Liang, Y ;
Jetton, TL ;
Lubkin, M ;
Meier, AH ;
Cincotta, AH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (07) :703-711
[34]   Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of oblob mice [J].
Liang, Y ;
Lubkin, M ;
Sheng, H ;
Scislowski, PWD ;
Cincotta, AH .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1998, 1405 (1-3) :1-13
[35]   Sex differences in circulating human leptin pulse amplitude: Clinical implications [J].
Licinio, J ;
Negrao, AB ;
Mantzoros, C ;
Kaklamani, V ;
Wong, ML ;
Bongiorno, PB ;
Negro, PP ;
Mulla, A ;
Veldhuis, JD ;
Cearnal, L ;
Flier, JS ;
Gold, PW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) :4140-4147
[36]   Bromocriptine reduces obesity, glucose intolerance and extracellular monoamine metabolite levels in the ventromedial hypothalamus of Syrian hamsters [J].
Luo, SQ ;
Meier, AH ;
Cincotta, AH .
NEUROENDOCRINOLOGY, 1998, 68 (01) :1-10
[37]  
Ma ZM, 1996, CLIN CHEM, V42, P942
[38]   Cerebrospinal fluid leptin in anorexia nervosa: Correlation with nutritional status and potential role in resistance to weight gain [J].
Mantzoros, C ;
Flier, JS ;
Lesem, MD ;
Brewerton, TD ;
Jimerson, DC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1845-1851
[39]   Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men [J].
Mantzoros, CS ;
Liolios, AD ;
Tritos, NA ;
Kaklamani, VG ;
Doulgerakis, DE ;
Griveas, I ;
Moses, AC ;
Flier, JS .
OBESITY RESEARCH, 1998, 6 (03) :179-186
[40]   TIMED BROMOCRIPTINE ADMINISTRATION REDUCES BODY-FAT STORES IN OBESE SUBJECTS AND HYPERGLYCEMIA IN TYPE-II DIABETICS [J].
MEIER, AH ;
CINCOTTA, AH ;
LOVELL, WC .
EXPERIENTIA, 1992, 48 (03) :248-253